Sodium-chloride difference and metabolic syndrome: A population-based large-scale cohort study

Internal Medicine

Volumn 55, Issue 21, 2016, Pages 3085-3090

  Kimura, Toshihiro ^a   Hashimoto, Yoshitaka ^a   Tanaka, Muhei ^a   Asano, Mai ^a   Yamazaki, Masahiro ^a   Oda, Yohei ^a   Toda, Hitoshi ^b   Marunaka, Yoshinori ^c   Nakamura, Naoto ^a   Fukui, Michiaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Oike Clinic   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Anion gap; Electrolyte; Epidemiology; Metabolic syndrome; Serum chloride; Serum sodium

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM CHLORIDE; CHLORIDE; SODIUM;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EVALUATION AND FOLLOW UP; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; POPULATION BASED CASE CONTROL STUDY; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; HYPOKALEMIA; JAPAN; LONGITUDINAL STUDY; ODDS RATIO; PATHOPHYSIOLOGY; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHLORIDES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERNATREMIA; HYPOKALEMIA; JAPAN; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM;

EID: 84994174434     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.55.7000     Document Type: Article

References (25)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
2. Sone H, Tanaka S, Iimuro S, et al. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS). J Atheroscler Thromb 16: 380-387, 2009.
3. Nagahama S, Kurotani K, Pham NM, et al. Self-reported eating rate and metabolic syndrome in Japanese people: cross-sectional study. BMJ Open 4: e005241, 2014.
4. Miyatake N, Kawasaki Y, Nishikawa H, Takenami S, Numata T. Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern Med 45: 107-108, 2006.
5. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 170: 294-302, 2010.
6. Deubner N, Berliner D, Frey A, et al. Dysnatraemia in heart failure. Eur J Heart Fail 14: 1147-1154, 2012.
7. Kovesdy CP, Lott EH, Lu JL, et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 125: 677-684, 2012.
8. Kovesdy CP. Significance of hypo- and hypernatremia in chronic kidney disease. Nephrol Dial Transplant 27: 891-898, 2012.
9. Oh SW, Baek SH, An JN, et al. Small increases in plasma sodium are associated with higher risk of mortality in a healthy population. J Korean Med Sci 28: 1034-1040, 2013.
10. McCallum L, Jeemon P, Hastie CE, et al. Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension 62: 836-843, 2013.
11. Hashimoto Y, Tanaka M, Kimura T, et al. Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study. Endocrine 50: 390-396, 2015.
12. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982- 992, 2009.
13. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 120: 1640-1645, 2009.
14. Ota T, Takamura T, Hirai N, Kobayashi K. Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care 25: 1252-1253, 2002.
15. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143: 722-728, 2005.
16. Definition and the diagnostic standard for metabolic syndrome -Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nihon Naika Gakkai Zasshi (J Jpn Soc Int Med) 94: 794-809, 2005 (in Japanese).
17. Taylor EN, Forman JP, Farwell WR. Serum anion gap and blood pressure in the national health and nutrition examination survey. Hypertension 50: 320-324, 2007.
18. Forman JP, Rifas-Shiman SL, Taylor EN, Lane K, Gillman MW. Association between the serum anion gap and blood pressure among patients at Harvard Vanguard Medical Associates. J Hum Hypertens 22: 122-125, 2008.
19. Farwell WR, Taylor EN. Serum anion gap, bicarbonate and biomarkers of inflammation in healthy individuals in a national survey. CMAJ 182: 137-141, 2010.
20. Farwell WR, Taylor EN. Serum bicarbonate, anion gap and insulin resistance in the National Health and Nutrition Examination Survey. Diabet Med 25: 798-804, 2008.
21. Koeppen BM. The kidney and acid-base regulation. Adv Physiol Educ 33: 275-281, 2009.
22. Sluijs I, Beulens JW, van der A DL, Spijkerman AM, Grobbee DE, van der Schouw YT. Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL study. Diabetes Care 33: 43-48, 2010.
23. Fagherazzi G, Vilier A, Bonnet F, et al. Dietary acid load and risk of type 2 diabetes: the E3N-EPIC cohort study. Diabetologia 57: 313-320, 2014.
24. Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol 10: 578-583, 2015.
25. Examination Committee of Criteria for ‘Obesity Disease’ in Ja-pan，Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J 66: 987-992, 2002.